Kevin Norrett is the Chief Operating Officer at Codexis, Inc., a biotechnology company focused on creating solutions for a more sustainable world. He has extensive experience in the biopharmaceutical industry, previously holding key positions like Chief Business Officer at Sierra...

Kevin Norrett is the Chief Operating Officer at Codexis, Inc., a biotechnology company focused on creating solutions for a more sustainable world. He has extensive experience in the biopharmaceutical industry, previously holding key positions like Chief Business Officer at Sierra Oncology and Chief Commercial Officer at Angion Biomedica. Kevin has a strong educational background with an M.B.A. from UC Berkeley, and before that, he earned degrees in Biological Sciences and Biochemistry from UC Davis and UCLA, respectively. In 2023, he earned a total compensation of about $1.09 million, which includes base salary, bonuses, and stock options. His recent insider trading activity suggests he has confidence in the company’s future, with notable trades throughout 2023 totaling over $4 million. Since joining Codexis in October 2022, he has been an integral part of the team, working to boost the company's mission and performance.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other Codexis CEOs

C

Kevin Norrett

CEO of Codexis

Education

M.B.A. from University of California, Berkeley.

Field of Expertise

Healthcare & Life Sciences - Biotechnology

Sector of Economy

Healthcare

Born

January 1, 1977 - 48 years ago

CEO of Codexis for

2 years 9 months (Sep 2022 - Present)

Previous Experience

Various roles in biotechnology and pharmaceutical companies, including Chief Business Officer at Sierra Oncology.

Rivals

Competitors/colleagues of Kevin Norrett

Holdings

See how much did Kevin Norrett make over time.

Kevin Norrett's holdings in Codexis reflect his commitment to the company. Throughout 2023, he made multiple insider trades, showing confidence in Codexis' performance. His trades ranged from $189,000 to over $688,000 each month, totaling more than $4 million for the...

Kevin Norrett's holdings in Codexis reflect his commitment to the company. Throughout 2023, he made multiple insider trades, showing confidence in Codexis' performance. His trades ranged from $189,000 to over $688,000 each month, totaling more than $4 million for the year. Such activity indicates Norrett's strong belief in the company's future and his strategic role in driving growth. Currently, his wealth is significantly tied to his stock options and shares in Codexis, which aligns his interests with those of shareholders. He has a vested stock value of $83,000 from 2023, with a larger stock option grant worth about $1.5 million that will vest over the coming years.

Mar 18, 2025

C

shares

CDXS @ $2.73

Total Stock Sold

$77.03K

CDXS

$77.03K

16,854 CDXS shares

What if they kept their stock?

If Kevin Norrett didn't sell their stock, today they would have:
Extra CDXS16,854 shares worth $186.57K.
This is 142.2% and $109.54K more than what they got when they sold the stock.

Insider Trading

See recent insider trades of Kevin Norrett.

CDXS

53,750 shares

CDXS

Feb 5, 2025

Received

CDXS

52,350 shares

CDXS

Jan 1, 2024

Received

CDXS

$15.48K

CDXS at $1.72/share

Sep 11, 2023

Purchase

CDXS

$77.17K

CDXS at $4.58/share

Feb 8, 2023

Sale

CDXS

22,500 shares

CDXS

Feb 21, 2023

Received

CDXS

83,456 shares

CDXS

Feb 8, 2023

Received

Compensation History

See how much did Kevin Norrett make over time.

In 2023, Kevin Norrett's total compensation peaked at approximately $1,090,880, a significant increase from the previous year. His earnings comprised a base salary of $468,000, a performance-based bonus of $257,400, and vested stock valued at around $83,039. His salary reflects a strategic alignment with the company’s goals, with bonuses tied to corporate performance metrics. This structure is designed to motivate and retain top talent, ensuring that executives like Norrett are focused on driving the company’s success. In 2022, his compensation was only $275,835, showing noticeable growth in his financial recognition as he continues to lead efforts at Codexis.

Year

2023

Total Compensation

$822.60K

Salary

$468.00K

Board Justification

The compensation philosophy is designed to attract and retain talented individuals, aligning executive compensation with company performance and market competitiveness.

Bonus

$257.40K

Board Justification

The bonus was based on corporate performance metrics, with a target bonus percentage of 50% of annual base salary, adjusted to 110% of target based on performance achievement.

Other

$14.16K

Board Justification

Other compensation includes a cell phone stipend and 401(k) matching contributions.

Restricted Stock

$83.04K(41.73K RSU)

Board Justification

The vested stock represents restricted stock units that vested in 2023, with a total of 22,500 RSUs granted in February 2023, vesting in three equal installments over three years, subject to continued service.

Performance Metrics

Performance metrics for 2023 included strategic financial deliverables, product revenue, gross margin, and R&D revenue, with a maximum achievement level capped at 150%.

Other Codexis CEOs

Here are other CEOs of Codexis

John Nicols

Ex-CEO of Codexis

November 2017 - September 2022